{"id":781,"date":"2016-06-01T13:45:00","date_gmt":"2016-06-01T13:45:00","guid":{"rendered":""},"modified":"2019-08-07T10:35:13","modified_gmt":"2019-08-07T14:35:13","slug":"clinical-development-success-rates-d57","status":"publish","type":"post","link":"https:\/\/qcroc.ca\/en\/clinical-development-success-rates-d57\/","title":{"rendered":"Clinical Development Success Rates"},"content":{"rendered":"<p class=\"font_8\">&nbsp;<\/p>\n<p class=\"align-center font_8\"><img decoding=\"async\" alt=\"\" height=\"417.3333333333333\" src=\"https:\/\/qcroc.ca\/wp-content\/uploads\/2019\/08\/79b96a_e1bc5146c48a4a79b69ef23141d933c5-mv2_d_8490_5660_s_4_2.jpg\" width=\"626\" wix-comp=\"{&quot;id&quot;:&quot;innercomp_bkwl27cr&quot;,&quot;dataQuery&quot;:&quot;bkwl27cr&quot;,&quot;propertyQuery&quot;:&quot;bkwl27cr&quot;,&quot;componentType&quot;:&quot;wysiwyg.viewer.components.WPhoto&quot;,&quot;styleId&quot;:&quot;&quot;,&quot;skin&quot;:&quot;wysiwyg.viewer.skins.photo.NoSkinPhoto&quot;,&quot;display&quot;:&quot;block&quot;,&quot;marginLeft&quot;:&quot;auto&quot;,&quot;marginRight&quot;:&quot;auto&quot;,&quot;width&quot;:1,&quot;src&quot;:&quot;\/\/static.wixstatic.com\/media\/79b96a_e1bc5146c48a4a79b69ef23141d933c5~mv2_d_8490_5660_s_4_2.jpg&quot;,&quot;isFullSize&quot;:false}\"><\/p>\n<p class=\"font_8\"><span>&nbsp;<\/span><\/p>\n<p class=\"font_8\">The&nbsp;Biotechnology Innovation Organization (BIO) has released the largest ever study of clinical development success rates, with a focus on&nbsp;the advantages of using biomarkers in clinical trials. &nbsp;<\/p>\n<p class=\"font_8\">&nbsp;<\/p>\n<p class=\"font_8\">Some of the conclusions:&nbsp;<\/p>\n<ul class=\"font_8\">\n<li>\n<p class=\"font_8\">Clinical trial programs that used selection biomarkers saw an overall likelihood of approval (LOA) from Phase I of 25.9%, compared to 8.4% when no selection biomarkers were used.<\/p>\n<\/li>\n<li>\n<p class=\"font_8\">Oncology drugs were approved the fastest of all 14 disease areas.<\/p>\n<\/li>\n<\/ul>\n<p class=\"font_8\">&nbsp;<\/p>\n<p class=\"font_8\">Read the study:&nbsp;<span style=\"\"><a href=\"http:\/\/bit.ly\/22o5TGf\"  target=\"_blank\" rel=\"noopener noreferrer\">http:\/\/bit.ly\/22o5TGf<\/a><\/span><\/p>\n<p class=\"font_8\">&nbsp;<\/p>\n<p class=\"font_8\">&nbsp;<\/p>\n<p class=\"font_8\">&nbsp;<\/p>\n<p class=\"font_8\">&nbsp;<\/p>\n<p class=\"font_8\">&nbsp;<\/p>\n<p class=\"font_8\">&nbsp;<\/p>\n<p class=\"font_8\">&nbsp;<\/p>\n<p class=\"font_8\">&nbsp;<\/p>\n<p class=\"font_8\">&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p class=\"excerpt\">&nbsp; &nbsp; The&nbsp;Biotechnology Innovation Organization (BIO) has released the largest ever study of clinical development success rates, with a focus on&nbsp;the advantages of using biomarkers in clinical trials. &nbsp; &nbsp; Some of the conclusions:&nbsp; Clinical trial programs that used selection biomarkers saw an overall likelihood of approval (LOA) from Phase I of 25.9%, compared to [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[],"tags":[],"keyword":[],"class_list":["post-781","post","type-post","status-publish","format-standard","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Clinical Development Success Rates - Clinical Research in Oncology<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/qcroc.ca\/en\/clinical-development-success-rates-d57\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clinical Development Success Rates - Clinical Research in Oncology\" \/>\n<meta property=\"og:description\" content=\"&nbsp; &nbsp; The&nbsp;Biotechnology Innovation Organization (BIO) has released the largest ever study of clinical development success rates, with a focus on&nbsp;the advantages of using biomarkers in clinical trials. &nbsp; &nbsp; Some of the conclusions:&nbsp; Clinical trial programs that used selection biomarkers saw an overall likelihood of approval (LOA) from Phase I of 25.9%, compared to [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/qcroc.ca\/en\/clinical-development-success-rates-d57\/\" \/>\n<meta property=\"og:site_name\" content=\"Clinical Research in Oncology\" \/>\n<meta property=\"article:published_time\" content=\"2016-06-01T13:45:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-08-07T14:35:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/qcroc.ca\/wp-content\/uploads\/2019\/08\/79b96a_e1bc5146c48a4a79b69ef23141d933c5-mv2_d_8490_5660_s_4_2.jpg\" \/>\n<meta name=\"author\" content=\"Fleexer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fleexer\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/qcroc.ca\/en\/clinical-development-success-rates-d57\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/qcroc.ca\/en\/clinical-development-success-rates-d57\/\"},\"author\":{\"name\":\"Fleexer\",\"@id\":\"https:\/\/qcroc.ca\/en\/#\/schema\/person\/01d3087ef85dfd3221ab50f2b6765f4f\"},\"headline\":\"Clinical Development Success Rates\",\"datePublished\":\"2016-06-01T13:45:00+00:00\",\"dateModified\":\"2019-08-07T14:35:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/qcroc.ca\/en\/clinical-development-success-rates-d57\/\"},\"wordCount\":98,\"publisher\":{\"@id\":\"https:\/\/qcroc.ca\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/qcroc.ca\/en\/clinical-development-success-rates-d57\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/qcroc.ca\/wp-content\/uploads\/2019\/08\/79b96a_e1bc5146c48a4a79b69ef23141d933c5-mv2_d_8490_5660_s_4_2.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/qcroc.ca\/en\/clinical-development-success-rates-d57\/\",\"url\":\"https:\/\/qcroc.ca\/en\/clinical-development-success-rates-d57\/\",\"name\":\"Clinical Development Success Rates - Clinical Research in Oncology\",\"isPartOf\":{\"@id\":\"https:\/\/qcroc.ca\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/qcroc.ca\/en\/clinical-development-success-rates-d57\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/qcroc.ca\/en\/clinical-development-success-rates-d57\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/qcroc.ca\/wp-content\/uploads\/2019\/08\/79b96a_e1bc5146c48a4a79b69ef23141d933c5-mv2_d_8490_5660_s_4_2.jpg\",\"datePublished\":\"2016-06-01T13:45:00+00:00\",\"dateModified\":\"2019-08-07T14:35:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/qcroc.ca\/en\/clinical-development-success-rates-d57\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/qcroc.ca\/en\/clinical-development-success-rates-d57\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/qcroc.ca\/en\/clinical-development-success-rates-d57\/#primaryimage\",\"url\":\"https:\/\/qcroc.ca\/wp-content\/uploads\/2019\/08\/79b96a_e1bc5146c48a4a79b69ef23141d933c5-mv2_d_8490_5660_s_4_2.jpg\",\"contentUrl\":\"https:\/\/qcroc.ca\/wp-content\/uploads\/2019\/08\/79b96a_e1bc5146c48a4a79b69ef23141d933c5-mv2_d_8490_5660_s_4_2.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/qcroc.ca\/en\/clinical-development-success-rates-d57\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/qcroc.ca\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Clinical Development Success Rates\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/qcroc.ca\/en\/#website\",\"url\":\"https:\/\/qcroc.ca\/en\/\",\"name\":\"Clinical Research in Oncology\",\"description\":\"Q-CROC rend la recherche clinique plus accessible et plus compr\u00e9hensible pour les professionnels de la sant\u00e9 et les personnes touch\u00e9es par le cancer\",\"publisher\":{\"@id\":\"https:\/\/qcroc.ca\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/qcroc.ca\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/qcroc.ca\/en\/#organization\",\"name\":\"Q-CROC\",\"url\":\"https:\/\/qcroc.ca\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/qcroc.ca\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/qcroc.ca\/wp-content\/uploads\/2019\/08\/qcroc.png\",\"contentUrl\":\"https:\/\/qcroc.ca\/wp-content\/uploads\/2019\/08\/qcroc.png\",\"width\":114,\"height\":56,\"caption\":\"Q-CROC\"},\"image\":{\"@id\":\"https:\/\/qcroc.ca\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/qcroc.ca\/en\/#\/schema\/person\/01d3087ef85dfd3221ab50f2b6765f4f\",\"name\":\"Fleexer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/qcroc.ca\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/qcroc.ca\/wp-content\/litespeed\/avatar\/a71338683c66af31fd32533c11a02ee6.jpg?ver=1794439491\",\"contentUrl\":\"https:\/\/qcroc.ca\/wp-content\/litespeed\/avatar\/a71338683c66af31fd32533c11a02ee6.jpg?ver=1794439491\",\"caption\":\"Fleexer\"},\"url\":\"https:\/\/qcroc.ca\/en\/author\/fleexer\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Clinical Development Success Rates - Clinical Research in Oncology","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/qcroc.ca\/en\/clinical-development-success-rates-d57\/","og_locale":"en_US","og_type":"article","og_title":"Clinical Development Success Rates - Clinical Research in Oncology","og_description":"&nbsp; &nbsp; The&nbsp;Biotechnology Innovation Organization (BIO) has released the largest ever study of clinical development success rates, with a focus on&nbsp;the advantages of using biomarkers in clinical trials. &nbsp; &nbsp; Some of the conclusions:&nbsp; Clinical trial programs that used selection biomarkers saw an overall likelihood of approval (LOA) from Phase I of 25.9%, compared to [&hellip;]","og_url":"https:\/\/qcroc.ca\/en\/clinical-development-success-rates-d57\/","og_site_name":"Clinical Research in Oncology","article_published_time":"2016-06-01T13:45:00+00:00","article_modified_time":"2019-08-07T14:35:13+00:00","og_image":[{"url":"https:\/\/qcroc.ca\/wp-content\/uploads\/2019\/08\/79b96a_e1bc5146c48a4a79b69ef23141d933c5-mv2_d_8490_5660_s_4_2.jpg","type":"","width":"","height":""}],"author":"Fleexer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Fleexer"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/qcroc.ca\/en\/clinical-development-success-rates-d57\/#article","isPartOf":{"@id":"https:\/\/qcroc.ca\/en\/clinical-development-success-rates-d57\/"},"author":{"name":"Fleexer","@id":"https:\/\/qcroc.ca\/en\/#\/schema\/person\/01d3087ef85dfd3221ab50f2b6765f4f"},"headline":"Clinical Development Success Rates","datePublished":"2016-06-01T13:45:00+00:00","dateModified":"2019-08-07T14:35:13+00:00","mainEntityOfPage":{"@id":"https:\/\/qcroc.ca\/en\/clinical-development-success-rates-d57\/"},"wordCount":98,"publisher":{"@id":"https:\/\/qcroc.ca\/en\/#organization"},"image":{"@id":"https:\/\/qcroc.ca\/en\/clinical-development-success-rates-d57\/#primaryimage"},"thumbnailUrl":"https:\/\/qcroc.ca\/wp-content\/uploads\/2019\/08\/79b96a_e1bc5146c48a4a79b69ef23141d933c5-mv2_d_8490_5660_s_4_2.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/qcroc.ca\/en\/clinical-development-success-rates-d57\/","url":"https:\/\/qcroc.ca\/en\/clinical-development-success-rates-d57\/","name":"Clinical Development Success Rates - Clinical Research in Oncology","isPartOf":{"@id":"https:\/\/qcroc.ca\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/qcroc.ca\/en\/clinical-development-success-rates-d57\/#primaryimage"},"image":{"@id":"https:\/\/qcroc.ca\/en\/clinical-development-success-rates-d57\/#primaryimage"},"thumbnailUrl":"https:\/\/qcroc.ca\/wp-content\/uploads\/2019\/08\/79b96a_e1bc5146c48a4a79b69ef23141d933c5-mv2_d_8490_5660_s_4_2.jpg","datePublished":"2016-06-01T13:45:00+00:00","dateModified":"2019-08-07T14:35:13+00:00","breadcrumb":{"@id":"https:\/\/qcroc.ca\/en\/clinical-development-success-rates-d57\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/qcroc.ca\/en\/clinical-development-success-rates-d57\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/qcroc.ca\/en\/clinical-development-success-rates-d57\/#primaryimage","url":"https:\/\/qcroc.ca\/wp-content\/uploads\/2019\/08\/79b96a_e1bc5146c48a4a79b69ef23141d933c5-mv2_d_8490_5660_s_4_2.jpg","contentUrl":"https:\/\/qcroc.ca\/wp-content\/uploads\/2019\/08\/79b96a_e1bc5146c48a4a79b69ef23141d933c5-mv2_d_8490_5660_s_4_2.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/qcroc.ca\/en\/clinical-development-success-rates-d57\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/qcroc.ca\/en\/"},{"@type":"ListItem","position":2,"name":"Clinical Development Success Rates"}]},{"@type":"WebSite","@id":"https:\/\/qcroc.ca\/en\/#website","url":"https:\/\/qcroc.ca\/en\/","name":"Clinical Research in Oncology","description":"Q-CROC rend la recherche clinique plus accessible et plus compr\u00e9hensible pour les professionnels de la sant\u00e9 et les personnes touch\u00e9es par le cancer","publisher":{"@id":"https:\/\/qcroc.ca\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/qcroc.ca\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/qcroc.ca\/en\/#organization","name":"Q-CROC","url":"https:\/\/qcroc.ca\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/qcroc.ca\/en\/#\/schema\/logo\/image\/","url":"https:\/\/qcroc.ca\/wp-content\/uploads\/2019\/08\/qcroc.png","contentUrl":"https:\/\/qcroc.ca\/wp-content\/uploads\/2019\/08\/qcroc.png","width":114,"height":56,"caption":"Q-CROC"},"image":{"@id":"https:\/\/qcroc.ca\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/qcroc.ca\/en\/#\/schema\/person\/01d3087ef85dfd3221ab50f2b6765f4f","name":"Fleexer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/qcroc.ca\/en\/#\/schema\/person\/image\/","url":"https:\/\/qcroc.ca\/wp-content\/litespeed\/avatar\/a71338683c66af31fd32533c11a02ee6.jpg?ver=1794439491","contentUrl":"https:\/\/qcroc.ca\/wp-content\/litespeed\/avatar\/a71338683c66af31fd32533c11a02ee6.jpg?ver=1794439491","caption":"Fleexer"},"url":"https:\/\/qcroc.ca\/en\/author\/fleexer\/"}]}},"_links":{"self":[{"href":"https:\/\/qcroc.ca\/en\/wp-json\/wp\/v2\/posts\/781"}],"collection":[{"href":"https:\/\/qcroc.ca\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/qcroc.ca\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/qcroc.ca\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/qcroc.ca\/en\/wp-json\/wp\/v2\/comments?post=781"}],"version-history":[{"count":0,"href":"https:\/\/qcroc.ca\/en\/wp-json\/wp\/v2\/posts\/781\/revisions"}],"wp:attachment":[{"href":"https:\/\/qcroc.ca\/en\/wp-json\/wp\/v2\/media?parent=781"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/qcroc.ca\/en\/wp-json\/wp\/v2\/categories?post=781"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/qcroc.ca\/en\/wp-json\/wp\/v2\/tags?post=781"},{"taxonomy":"keyword","embeddable":true,"href":"https:\/\/qcroc.ca\/en\/wp-json\/wp\/v2\/keyword?post=781"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}